176794-96-0Relevant articles and documents
IL-17 Ligands And Uses Thereof
-
Paragraph 0443-0444, (2020/08/20)
Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
HPTP-BETA INHIBITORS
-
, (2015/10/05)
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility ar